Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Schoenhals

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|March 22, 2017
Optimizing Radiotherapy with Immunotherapeutic ApproachesJonathan E Schoenhals, Tijana Skrepnik, Ugur Selek, et al.
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid TumorsEric D Brooks, Jonathan E Schoenhals, Chad Tang, et al.
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local ControlJonathan E Schoenhals, Steven N Seyedin, Chad Tang, et al.
Frontiers in Immunology|October 9, 2018
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal EffectsJonathan E Schoenhals, Taylor R Cushman, Hampartsoum B Barsoumian, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2019
IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Translational Lung Cancer Research|May 23, 2017
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiationJonathan E Schoenhals, Steven N Seyedin, Clark Anderson, et al.
Immunotherapy|February 10, 2018
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, et al.
Cancer Letters|May 11, 2018
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cellsAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Prostate Cancer|January 19, 2026
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19)Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun, et al.
Advances in Radiation Oncology|October 14, 2021
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell CarcinomaJonathan E Schoenhals, Osama Mohamad, Alana Christie, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|March 22, 2017
Optimizing Radiotherapy with Immunotherapeutic ApproachesJonathan E Schoenhals, Tijana Skrepnik, Ugur Selek, et al.
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid TumorsEric D Brooks, Jonathan E Schoenhals, Chad Tang, et al.
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local ControlJonathan E Schoenhals, Steven N Seyedin, Chad Tang, et al.
Frontiers in Immunology|October 9, 2018
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal EffectsJonathan E Schoenhals, Taylor R Cushman, Hampartsoum B Barsoumian, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2019
IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Translational Lung Cancer Research|May 23, 2017
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiationJonathan E Schoenhals, Steven N Seyedin, Clark Anderson, et al.
Immunotherapy|February 10, 2018
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, et al.
Cancer Letters|May 11, 2018
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cellsAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Prostate Cancer|January 19, 2026
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19)Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun, et al.
Advances in Radiation Oncology|October 14, 2021
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell CarcinomaJonathan E Schoenhals, Osama Mohamad, Alana Christie, et al.
Pageof 3